Literature DB >> 18769287

Neurosarcoidosis mimicking a malignant optic glioma.

Jeffrey M Pollock1, Francis G Greiner, Jason B Crowder, Jessica W Crowder, Eugene Quindlen.   

Abstract

A 55-year-old African-American man developed progressive unilateral optic neuropathy and periocular pain. MRI showed thickening and enhancement of the mid-orbital segment of the ipsilateral optic nerve. Optic neuritis was diagnosed, and he was treated with corticosteroids without improvement. After being lost to follow-up, he returned with worsening vision in the affected eye, aggravated pain, and proptosis. MRI now showed thickening and enhancement of the entire orbital and intracranial segments of the optic nerve. Because the patient had no light perception vision in that eye and a malignant glioma was suspected, he underwent optic nerve biopsy that revealed non-caseating granulomas throughout the optic nerve tissue. CT body imaging failed to disclose other evidence of sarcoidosis. Neurosarcoidosis limited to the optic nerve is rare but should always be suspected in such circumstances. An exhaustive effort to find extracranial evidence for this diagnosis should be undertaken before resorting to optic nerve biopsy.

Entities:  

Mesh:

Year:  2008        PMID: 18769287     DOI: 10.1097/WNO.0b013e3181772a36

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  3 in total

Review 1.  Orbital and anterior visual pathway infection and inflammation.

Authors:  Roel De Wyngaert; Ingele Casteels; Philippe Demaerel
Journal:  Neuroradiology       Date:  2009-02-17       Impact factor: 2.804

2.  Orbital sarcoidosis presenting as diffuse swelling of the lower eyelid.

Authors:  Jeong Kyu Lee; Nam Ju Moon
Journal:  Korean J Ophthalmol       Date:  2013-01-15

3.  Malignant optic glioma masked by suspected optic neuritis and central retinal vein occlusion.

Authors:  Aleksandrs Kalnins; Mrudula Penta; Tarek El-Sawy; Y Joyce Liao; Nancy Fischbein; Michael Iv
Journal:  Radiol Case Rep       Date:  2018-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.